Trabectedin (Yondelis®) in Soft Tissue Sarcoma

被引：0

作者：

Zintl, Patrik ^{[1
]}

Santabarbara, Pedro ^{[1
]}

机构：

[1] Pharma Mar SAU, Madrid, Spain

来源：

METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 2008年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：29 / 31

页数：3

共 5 条

[1]

Brennan Murray F., 1997, P1738

[2]

*EMEA, 2007, YOND SUMM PROD CHAR

[3] Population pharmacokinetic meta-analysis of trabectedin (ET-743, Yondelis®) in cancer patients [J].

Jose Perez-Ruixo, Juan ;

Zannikos, Peter ;

Hirankarn, Sarapee ;

Stuyckens, Kim ;

Ludwig, Elizabeth A. ;

Soto-Matos, Arturo ;

Lopez-Lazaro, Luis ;

Owen, Joel S. .

CLINICAL PHARMACOKINETICS, 2007, 46 (10) :867-884

[4]

MORGAN JA, 2007, J CLIN ONCOL S, V25

[5] Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients [J].

Yovine, A ;

Riofrio, M ;

Blay, JY ;

Brain, E ;

Alexandre, J ;

Kahatt, C ;

Taamma, A ;

Jimeno, J ;

Martin, C ;

Salhi, Y ;

Cvitkovic, E ;

Misset, JL .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :890-899

← 1 →